Phase 2 Study of Belatacept, Alemtuzumab, and Sirolimus in Renal Transplantation
Administered By
Awarded By
Contributors
- Kirk, Allan Douglas Principal Investigator
- Parker, William Investigator
- Xu, He Co Investigator
Start/End
- February 1, 2015 - July 31, 2020